“…52 We further anticipate a strategy of chondroprotection where a glucocorticoid, administered from the locale of the injury/repair site in a manner that provides its sustained release at much lower levels than clinical injections, can also impact tissue healing and repair of the engineered graft upon implantation. 41,42 While future plans are aimed at further optimization of the dex microsphere strategy, including the testing of other proinflammatory cytokines such as TNF-a and the evaluation of tissue integrative repair in a cartilage explant ring model, [113][114][115] the efficacy of our approach on cartilage repair will necessarily have to be evaluated in vivo.…”